KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Molina Healthcare (MOH) Research & Development (2016 - 2018)

Molina Healthcare (MOH) has disclosed Research & Development for 9 consecutive years, with $120.0 million as the latest value for Q1 2018.

  • Quarterly Research & Development fell 1.64% to $120.0 million in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $490.0 million through Mar 2018, up 2.08% year-over-year, with the annual reading at $492.0 million for FY2017, 1.44% up from the prior year.
  • Research & Development hit $120.0 million in Q1 2018 for Molina Healthcare, down from $123.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $127.0 million in Q1 2016 to a low of $33.0 million in Q2 2015.
  • Historically, Research & Development has averaged $85.1 million across 5 years, with a median of $116.0 million in 2016.
  • Biggest five-year swings in Research & Development: dropped 15.14% in 2015 and later skyrocketed 252.78% in 2016.
  • Year by year, Research & Development stood at $39.2 million in 2014, then skyrocketed by 129.77% to $90.0 million in 2015, then soared by 36.67% to $123.0 million in 2016, then changed by 0.0% to $123.0 million in 2017, then dropped by 2.44% to $120.0 million in 2018.
  • Business Quant data shows Research & Development for MOH at $120.0 million in Q1 2018, $123.0 million in Q4 2017, and $123.0 million in Q3 2017.